Integra LifeSciences to Present at the 2023 Wells Fargo Healthcare Conference
01 Setembro 2023 - 6:04PM
Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading
global medical technology company, announced today that Lea Knight,
chief financial officer will present at the 2023 Wells Fargo
Healthcare Conference on September 6, 2023 at 1:30 p.m. EST.
A live webcast of the presentation will be
available on the Integra LifeSciences investor relations website at
http://investor.integralife.com/events-and-presentations.
About Integra LifeSciencesAt Integra
LifeSciences, we are driven by our purpose of restoring patients’
lives. We innovate treatment pathways to advance patient outcomes
and set new standards of surgical, neurologic and regenerative
care. We offer a comprehensive portfolio of high quality,
leadership brands that include AmnioExcel®, Aurora®, Bactiseal®,
BioD™, CerebroFlo®, CereLink® Certas® Plus, Codman®, CUSA®, Cytal®,
DuraGen®, DuraSeal®, DuraSorb®, Gentrix®, ICP Express®, Integra®,
Licox®, MAYFIELD®, MediHoney®, MicroFrance®, MicroMatrix®,
NeuraGen®, NeuraWrap™, PriMatrix®, SurgiMend®, TCC-EZ® and
VersaTru®. For the latest news and information about Integra and
its products, please visit www.integralife.com.
Investor Relations:Chris
Ward(609) 772-7736chris.ward@integralife.com
Media Contact:Laurene
Isip(609) 208-8121laurene.isip@integralife.com
Integra LifeSciences (NASDAQ:IART)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Integra LifeSciences (NASDAQ:IART)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024